|
gptkb:atrazine
|
inhibits photosystem II
|
|
gptkb:Roundup_Extended_Control
|
residual
|
|
gptkb:Elidel
|
gptkb:immunosuppressant
|
|
gptkb:gavo-cel_(TC-210)
|
genetically engineered T cells expressing a mesothelin-targeted TCR fusion construct
|
|
gptkb:BIBW_2992
|
gptkb:EGFR_inhibitor
|
|
gptkb:V-series_nerve_agents
|
gptkb:acetylcholinesterase_inhibitor
|
|
gptkb:Braftovi
|
gptkb:BRAF_inhibitor
|
|
gptkb:Fenspiride
|
anti-inflammatory
|
|
gptkb:123246-29-7
|
inhibits aromatase enzyme
|
|
gptkb:IGO-INGO_Access_to_Curative_Rights_Protection_Mechanisms
|
gptkb:Uniform_Rapid_Suspension_System
|
|
gptkb:paroxetine
|
inhibits reuptake of serotonin
|
|
gptkb:Kimmtrak
|
redirects T cells to tumor cells
|
|
gptkb:panobinostat
|
inhibits histone deacetylases
|
|
gptkb:Automaton_XIV_(steam_vehicle)
|
steam pressure moves wheels
|
|
gptkb:butamirate
|
cough center suppressant
|
|
gptkb:Roaccutane
|
reduces sebaceous gland size
|
|
gptkb:lanreotide
|
inhibits glucagon secretion
|
|
gptkb:STAT_transcription_factors
|
nuclear translocation
|
|
gptkb:CHEMBL656
|
beta-1 adrenergic receptor antagonist
|
|
gptkb:Cushing_ulcer
|
increased gastric acid secretion
|